- Cannabis industry investment builder Nabis Holdings has purchased Desert Hot Springs’ Desert’s Finest dispensary
- The new asset gives Nabis an entry point into the world’s largest cannabis industry market, and it is strategically located near the annual Coachella Music Festival
- Nabis envisions revenues of C$14.8 million this year with a leap to C$167.9 million next year, translating into forecasts of C$4.1 million in profits this year and C$67.5 million in 2020
The remarkable rise of the cannabis industry and its variety of sectors has created a sea change in some market metrics, drawing investors’ risk capital from last year’s newsmakers (http://ibn.fm/R8ubX). At the forefront of the trend, Nabis Holdings Inc. (CSE: NAB) (OTC: NABIF) (FRA: 71P) has been plying its experience in building an expanding portfolio of cannabis investments to create high-quality cash flow opportunities in states where limited licenses are granted for professional operations.
Nabis entered new territory with its first acquisition in California – the world’s largest market for the cannabis industry – which it announced in a June 12 news release noting a definitive agreement to acquire 100 percent ownership of Desert’s Finest, a 6,000-square-foot dispensary located in Desert Hot Springs, less than two hours east of Los Angeles (http://ibn.fm/9V5Jg).
“As we continue national expansion of the Nabis footprint, we are pleased to announce our first acquisition in the state of California, one of the dominant cannabis markets in the United States,” Nabis CEO and Director Shay Shnet stated in a news release. “Desert’s Finest has successfully generated material revenue driven in part by their convenient dispensary location in the Palm Springs region and extensive list of registered patients.”
The dispensary has more than 37,000 registered patients and brought in more than $5.7 million in revenues over the previous 12 months, leaving it with a 47 percent gross profit margin. Desert’s Finest’s location, strategically close to the annual Coachella Music Festival, has also shown to be a boon to sales of a wide assortment of flower, vape and edibles products.
Nabis expects that its portfolio of investments at a proper pricing point supports revenue forecasts of C$14.8 million this year followed by a leap to C$167.9 million next year as the company’s assets begin reaping the benefits of cultivation and harvest work. Most of those are due to expectations for strategically located assets in Michigan, where the company is building a pipeline of one cultivation facility, one processing facility and seven dispensaries.
Nabis expects the sales to translate into EBITDA of C$4.1 million in 2019 and C$67.5 million in 2020 (http://ibn.fm/5sMQa) as it builds a vertically integrated portfolio across the United States and expands into international markets.
The company’s investments include a cannabis cultivation facility, a greenhouse and a dispensary in Arizona, as well as a growing processing facility operation in Washington. In Israel, Nabis recently announced its 49 percent interest in sublingual cannabis strip maker Cannova Medical Ltd., with an option to purchase the remaining 51 percent at the company’s discretion.
Nabis also is examining multiple “off market” opportunities in Massachusetts, Nevada, Ohio, Oklahoma, Oregon and the European Union.
For more information, visit the company’s website at www.NabisHoldings.com
NOTE TO INVESTORS: The latest news and updates relating to NABIF are available in the company’s newsroom at http://ibn.fm/NABIF
QualityStocks is committed to connecting subscribers with companies that have huge potential to succeed in the short and long-term future. It is part of our mission statement to help the investment community discover emerging companies that offer excellent growth potential. We offer several ways for investors to learn more about investing in these companies as well as find and evaluate them.